Sponsor:
Mirati Therapeutics Inc.
Code:
NCT07415031
Conditions
Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Adagrasib
Pembrolizumab
Cetuximab
Pemetrexed
Docetaxel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-06. This information was provided to ClinicalTrials.gov by Mirati Therapeutics Inc. on 2026-06-30.